動物用ワクチンの市場規模、シェア、成長分析、製品別、投与経路別、地域別 - 産業別予測、2024～2031年

動物用ワクチンの世界市場規模は2022年に124億米ドルと評価され、2023年の135億9,000万米ドルから2031年には283億米ドルに成長し、予測期間中（2024-2031年）のCAGRは9.60%で成長する見通しです。

動物疾患の発生率の上昇と家畜数の増加により、特に牛に対する反芻動物ワクチンの世界的な受け入れが大幅に増加しています。動物は肉、牛乳、羊毛、皮革の生産に不可欠であるため、狂犬病、馬インフルエンザ、口蹄疫など、動物の健康と生産性を損なう病気を予防するためのワクチン接種の緊急性が高まっています。食糧安全保障をめぐる懸念の高まりと畜産業の急増が、こうしたワクチン需要をさらに押し上げています。人口増加とともに消費者の嗜好が進化するにつれ、畜産物に対する欲求も強まっています。さらに、ワクチン技術の進歩や頻発する疾病の発生が市場力学を再構築し、家畜ワクチン分野の継続的拡大に寄与しています。

目次

イントロダクション

• 調査の目的
• 調査範囲
• 定義

調査手法

• 情報調達
• 二次データと一次データの方法
• 市場規模予測
• 市場の前提条件と制限

エグゼクティブサマリー

• 世界市場の見通し
• 供給と需要の動向分析
• セグメント別機会分析

市場力学と見通し

• 市場概要
• 市場規模
• 市場力学
  • 促進要因と機会
  • 抑制要因と課題
• ポーター分析と影響
  • 競争企業間の敵対関係
  • 代替品の脅威
  • 買い手の交渉力
  • 新規参入業者の脅威
  • 供給企業の交渉力

主な市場の考察

• 重要成功要因
• 競合の程度
• 主な投資機会
• 市場エコシステム
• 市場の魅力指数（2023年）
• PESTEL分析
• マクロ経済指標
• バリューチェーン分析
• 価格分析
• 技術の進歩
• 規制情勢
• 特許分析
• ケーススタディ

動物用ワクチン市場規模：製品別

• 市場概要
• 弱毒生ワクチン
• 不活化ワクチン
• サブユニットワクチン
• DNAワクチン
• 組み換えワクチン

動物用ワクチン市場規模：投与経路別

• 市場概要
• 皮下
• 筋肉内
• 鼻腔内

動物用ワクチン市場規模：動物の種類別

• 市場概要
• 家畜
  • 家禽
  • 魚
  • 反芻動物
  • 豚
• コンパニオン
  • 犬
  • ネコ科
  • その他

動物用ワクチン市場規模：流通チャネル別

• 市場概要
• 小売り
• eコマース
• 病院・クリニック薬局

動物用ワクチン市場規模：地域別

• 北米
  • 米国
  • カナダ
• 欧州
  • 英国
  • ドイツ
  • スペイン
  • フランス
  • イタリア
  • その他欧州地域
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカ
  • ブラジル
  • その他ラテンアメリカ地域
• 中東・アフリカ
  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ

競合情報

• 上位5社の比較
• 主要企業の市場ポジショニング（2023年）
• 主な市場企業が採用した戦略
• 市場の最近の動向
• 企業の市場シェア分析（2023年）
• 主要企業の企業プロファイル
  • 会社概要
  • 製品ポートフォリオ分析
  • セグメント別シェア分析
  • 収益の前年比比較（2021-2023）

主要企業プロファイル

• Zoetis
• Merck & Co., Inc.
• Boehringer Ingelheim International GmbH
• Elanco Animal Health Inc.
• Bayer AG
• Virbac
• Ceva
• HIPRA
• Hester Biosciences Limited
• Biogenesis Bago
• Vaxxinova
• IDT Biologika GmbH
• Bimeda Animal Health
• BravoVax
• MSD Animal Health
• Agrovet Market Animal Health
• Anicon Labor GmbH

結論と推奨事項

Global Animal Vaccines Market size was valued at USD 12.4 billion in 2022 and is poised to grow from USD 13.59 billion in 2023 to USD 28.30 billion by 2031, growing at a CAGR of 9.60% during the forecast period (2024-2031).

The rising incidence of animal diseases, coupled with a growing livestock population, is significantly boosting the global acceptance of ruminant vaccines, especially for cattle. With animals being vital for producing meat, milk, wool, and leather, there is an increased urgency for vaccination to prevent diseases like rabies, equine influenza, and foot-and-mouth disease that compromise animal health and productivity. The escalating concerns surrounding food security and the surge in animal husbandry practices are further driving demand for these vaccines. As consumer preferences evolve alongside population growth, the appetite for livestock products intensifies. Moreover, advancements in vaccine technology and frequent disease outbreaks are reshaping market dynamics, contributing to continued expansion in the livestock vaccination sector.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Animal Vaccines market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Animal Vaccines Market Segmental Analysis

Global Animal Vaccines Market is segmented by Product, Route of Administration, Animal Type, Distribution Channel, and region. Based on Product, the market is segmented into Attenuated Live Vaccines, Inactivated Vaccines, Subunit Vaccines, DNA Vaccines, and Recombinant Vaccines. Based on Route of Administration, the market is segmented into Subcutaneous, Intramuscular, and Intranasal. Based on Animal Type, the market is segmented into Livestock, and Companion Based on Distribution Channel, the market is segmented into Retail, E-Commerce, and Hospital/ Clinic Pharmacy. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Animal Vaccines Market

The Global Animal Vaccines market is significantly driven by the rising incidence of zoonotic diseases, which have a detrimental impact on human health and underscore the urgent need for effective animal immunization. The escalating threat posed by emerging and exotic diseases compromises not only human and animal well-being but also jeopardizes food security. With increasing human and animal populations, coupled with environmental changes and the globalization of trade and travel, there are heightened risks for pathogen transmission across species. Furthermore, advancements in technology have transformed animal vaccination practices, leading to substantial R&D breakthroughs. Traditional vaccination methods have paved the way for the development of recombinant vaccines, which offer enhanced safety benefits by eliminating exposure to live pathogens. These dynamics collectively drive the demand for innovative animal vaccines in today's market.

Restraints in the Global Animal Vaccines Market

The Global Animal Vaccines market faces significant constraints, particularly in developing regions such as Africa, Asia, and Latin America, where an estimated 600-900 million smallholder farmers manage livestock. The adoption of animal vaccinations among these farmers is hindered by multiple challenges, including a lack of awareness regarding the advantages of vaccination, financial limitations that prevent access to immunization products, and the inadequate supply chain that restricts availability. As a result, many livestock animals owned by smallholder farmers succumb to various diseases, leading to further economic hardships for these communities. Governments and organizations are implementing strategies to enhance the accessibility, availability, and affordability of animal vaccination to improve livestock health in these areas.

Market Trends of the Global Animal Vaccines Market

The Global Animal Vaccines market is poised for substantial growth, driven by a surge in public-private funding for targeted research initiatives and a heightened prevalence of animal diseases. Technological advancements are facilitating product innovations, presenting lucrative opportunities for market players. Future growth will be further supported by increasing strategic alliances, enhanced internet penetration, and heightened concerns regarding zoonotic diseases. Additionally, advancements in diagnostics and therapeutics in developing regions, coupled with rising per capita healthcare spending, will amplify market demand. Collectively, these factors are positioning the animal vaccines sector as a critical market trend in the evolving landscape of veterinary healthcare.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Driver & Opportunities
  • Restraints & Challenges
• Porters Analysis & Impact
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2023
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Technological Advancement
• Regulatory Landscape
• Patent Analysis
• Case Studies

Global Animal Vaccines Market Size by Product & CAGR (2024-2031)

• Market Overview
• Attenuated Live Vaccines
• Inactivated Vaccines
• Subunit Vaccines
• DNA Vaccines
• Recombinant Vaccines

Global Animal Vaccines Market Size by Route of Administration & CAGR (2024-2031)

• Market Overview
• Subcutaneous
• Intramuscular
• Intranasal

Global Animal Vaccines Market Size by Animal Type & CAGR (2024-2031)

• Market Overview
• Livestock
  • Poultry
  • Aqua
  • Ruminants
  • Swine
• Companion
  • Canine
  • Feline
  • Others

Global Animal Vaccines Market Size by Distribution Channel & CAGR (2024-2031)

• Market Overview
• Retail
• E-Commerce
• Hospital/ Clinic Pharmacy

Global Animal Vaccines Market Size & CAGR (2024-2031)

• North America, (Product, Route of Administration, Animal Type, Distribution Channel)
  • US
  • Canada
• Europe, (Product, Route of Administration, Animal Type, Distribution Channel)
  • UK
  • Germany
  • Spain
  • France
  • Italy
  • Rest of Europe
• Asia-Pacific, (Product, Route of Administration, Animal Type, Distribution Channel)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia Pacific
• Latin America, (Product, Route of Administration, Animal Type, Distribution Channel)
  • Brazil
  • Rest of Latin America
• Middle East & Africa, (Product, Route of Administration, Animal Type, Distribution Channel)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2023
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

• Zoetis
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck & Co., Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boehringer Ingelheim International GmbH
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Elanco Animal Health Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bayer AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Virbac
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ceva
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• HIPRA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hester Biosciences Limited
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biogenesis Bago
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Vaxxinova
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• IDT Biologika GmbH
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bimeda Animal Health
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BravoVax
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MSD Animal Health
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agrovet Market Animal Health
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Anicon Labor GmbH
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendation